Consortium Européen de l'Hémophilie AISBL
Consortium Européen de l'Hémophilie reported total assets of €2.36m at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Sep 2026).
By total assets for 2025, Consortium Européen de l'Hémophilie ranks among the 500 largest of the 1,495 companies in its sector (NACE 7320) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Consortium Européen de l'Hémophilie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity -11 % Total assets -17 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Consortium Européen de l'Hémophilie's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Sep 2026
- Year ended 31 Dec 2024filed on 24 Feb 2026
- Year ended 31 Dec 2023filed on 27 Oct 2024
- Year ended 31 Dec 2020filed on 29 Nov 2021
Consortium Européen de l'Hémophilie's financial analysis
- Solvency83.6%sector median: 55.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Consortium Européen de l'Hémophilie
9 active director(s) in the register.
and 3 more
Consortium Européen de l'Hémophilie's shareholders and holdings →Consortium Européen de l'Hémophilie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0887.106.966
- VAT number
- BE0887106966
- Peppol
- Registered · 0208:0887106966 · as of 12 Nov 2026
- Legal form
- AISBL
- Incorporated
- 08 Feb 2007
- Registered office
- 1040 Brussels
- Latest accounts
- 2025 · filed on 03 Sep 2026
- Activity
- Market research and public opinion polling (NACE 73200)
Consortium Européen de l'Hémophilie (AISBL) has been based in Brussels since 2007, active in: market research and public opinion polling. For 2025, it reports a net loss of 258,102 € and equity of €1.97m; its revenue is not published. Its solvency stands at 83.6%, above the median of its sector (55.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Consortium Européen de l'Hémophilie
Companies in the same business, of comparable size and area, outside its group.
- Ligue Cardiologique belge Activities of other membership organisations n.e.c. Ixelles · balance sheet €2.61m
- Alzheimer Belgique Activities of other membership organisations n.e.c. Etterbeek · balance sheet €2.62m
- European Policy Centre Market research and public opinion polling Brussels · balance sheet €3.00m
- Association des Médecins généralistes de la province de Luxembourg Activities of other membership organisations n.e.c. Tintigny · balance sheet €1.70m
- Andromeda Beheer Activities of other membership organisations n.e.c. Eeklo · balance sheet €3.49m
- Confédération of european paper industries Market research and public opinion polling Ixelles · balance sheet €1.85m
- Centrum voor Kwaliteitszorg West-Vlaanderen Consult & Service Market research and public opinion polling Kortrijk · balance sheet €3.16m
- Fonds pour la Chirurgie Cardiaque Activities of other membership organisations n.e.c. Brussels · balance sheet €4.78m
Frequently asked questions about Consortium Européen de l'Hémophilie
What is the revenue of Consortium Européen de l'Hémophilie?
Consortium Européen de l'Hémophilie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Consortium Européen de l'Hémophilie?
In Belgium, the VAT number is the company number prefixed with BE: BE0887106966 for Consortium Européen de l'Hémophilie, if the company is VAT-registered. Its company number (CBE) is 0887.106.966.
Where is the registered office of Consortium Européen de l'Hémophilie?
According to the CBE register, the registered office of Consortium Européen de l'Hémophilie is in 1040 Brussels.
What is the equity of Consortium Européen de l'Hémophilie?
At the close of the 2025 financial year, the equity of Consortium Européen de l'Hémophilie amounts to 1,969,483 €, a solvency of 83.6% of total assets.
Who manages Consortium Européen de l'Hémophilie?
The register lists 9 active mandates at Consortium Européen de l'Hémophilie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Consortium Européen de l'Hémophilie within its sector?
By total assets for 2025, Consortium Européen de l'Hémophilie ranks among the 500 largest of the 1,495 companies in its sector (NACE 7320) in Belgium that filed accounts for that financial year.
The full file of Consortium Européen de l'Hémophilie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →